unknown
Stage
About
Bird Rock Bio is a clinical-stage biopharmaceutical company developing immuno-inflammatory regulators and therapeutic antibodies for fibrotic and metabolic diseases. The company applies a proprietary platform (iCAPS) to discover treatments for indications including diabetic nephropathy and NASH.
Explore Bird Rock Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.